Introduction
The Merkel cell polyoma virus (MCPyV) has been reported in approximately 80% of human Merkel cell carcinomas (MCC). [1] [2] [3] [4] [5] [6] Accumulating evidence of clonal MCPyV integration and truncating large T (LTAg) antigen mutations restricted to MCC strongly support an etiopathogenic role of MCPyV in MCC. 1, 7 MCC is a rare and aggressive malignant neuroendocrine skin cancer of elderly and immunosuppressed patients. 8, 9 However, MCC patients are at a 30-fold increased risk to develop chronic lymphocytic leukemia (CLL) which as MCC primarily affects elderly patients. [10] [11] [12] CLL is the most common leukemia in the Western world and is characterized by the accumulation of monoclonal mature B cells aberrantly expressing CD5. 13 Recently, a large population based study has shown that CLL patients have a high risk of MCPyV 
SYBR green Real-Time PCR
Real-time PCR was performed as recently described.
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Immunohistochemistry
MCPyV immunohistochemistry (IHC) was performed with the monoclonal antibody CM2B4 (IgG2b isotype) as described recently. 19 Minor modifications included pH9.0 and a dilution of 1:1000 (vol/vol). CM2B4 was detected with the DAKO K5005 secondary detection kit (DAKO, Germany). Staining was performed using 3-amino-9-ethylcarbazole (AEC) substrate and counter-stained with hematoxylin ( Figure 1C ).
Prognostic factors
Prognostic factors were assessed as previously published. 20 For the determination of the CD38 status a threshold of 7% of positive stained CLL cells was applied for definition of CD38+ patients.
Results and discussion
McPyV detection in CLL and clinico-pathological correlations
To overcome possible dilution effects due to FFPE tissues or whole blood samples we tested 70 DNA samples derived from highly purified CD5+/CD19+ CLL cells. Of these, 19 (27.1%) were MCPyV-positive. Sixteen (22.8%) were positive by M1/M2
PCR, 1 (1.4%) by LT3 PCR and 2 (2.8%) by VP1 PCR ( were male and 3 were female. Taken together we here report a higher detection rate for MCPyV in CLL cases compared to the previous study which is most likely due to the optimal DNA quality derived from the freshly processed and preselected cell material which was used for the current study.
Mutational analysis of the large T gene
We tested the 19 MCPyV-positive CLL cases for previously reported truncating mutations eliminating the helicase domain in the C-terminus of the LTag. 7, 21 The loss of the helicase activity prevents MCPyV replication and clearly indicates that MCPyV is not a passenger virus in the tumor. 17 Six of the 19 MCPyV-positive CLL cases revealed a novel 246 bp deletion within the viral helicase gene (Fig. 1A and B) . In 2 CLL cases mutated LT was detected concomitant to wildtype MCPyV (Fig. 1A) . The 246 bp deletion terminates the open reading frame leading to a loss of the helicase domain and thus viral replication deficiency. In two of the mutated MCPyV-positive CLL cases formalin fixed and paraffin embedded material of diagnostic bone marrow trephines with nodular CLL infiltrates were available to confirm the presence of MCPyV protein (Fig. 1C) . The other 13 MCPyV-positive CLL cases revealed minor nucleotide exchanges not disrupting the ORF of LTAg (Fig. 1B) 
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